Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth

Emily C Dykhuizen1, John F May, Aimon Tongpenyai

  • 1Departments of Chemistry and Biochemistry, University of WisconsinMadison, Madison, Wisconsin 53706, USA.

Insights

Researchers identified novel aminothiazole inhibitors targeting UDP-galactopyranose mutase (UGM), an essential enzyme in mycobacteria. These compounds effectively block bacterial growth, offering a potential therapeutic strategy against mycobacterial infections.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Biochemistry

Background:

  • Galactofuranose (Galf) is crucial for mycobacterial cell walls.
  • UDP-galactopyranose mutase (UGM) synthesizes Galf and is essential for mycobacteria.
  • UGM is a promising therapeutic target due to its absence in humans.

Purpose of the Study:

  • To design and identify novel inhibitors of UDP-galactopyranose mutase (UGM).
  • To explore structure-activity relationships for developing effective UGM inhibitors.
  • To assess the efficacy of identified inhibitors against mycobacterial growth.

Main Methods:

  • Structure-activity relationship (SAR) studies.
  • Molecular design and synthesis of aminothiazole compounds.
  • Enzyme inhibition assays for UGM from Klebsiella pneumoniae and Mycobacterium tuberculosis.
  • Assessment of inhibitor activity against Mycobacterium smegmatis growth.

Main Results:

  • Several synthetic aminothiazole derivatives were identified as potent UGM inhibitors.
  • Inhibitors demonstrated efficacy against UGM from both K. pneumoniae and M. tuberculosis.
  • The identified compounds successfully inhibited the growth of M. smegmatis.

Conclusions:

  • Aminothiazoles represent a promising class of compounds for targeting mycobacterial UGM.
  • Inhibiting UGM is a viable strategy for developing new anti-mycobacterial therapeutics.
  • These findings support further development of UGM inhibitors for treating mycobacterial diseases.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!